by Elizabeth Kissling | Apr 22, 2010 | Birth Control, Disposable menstrual products, Menstruation, New Research, Pharmaceutical
So here’s an odd little study: when women are given a choice between oral contraceptives and the contraceptive vaginal ring, what characteristic is most highly correlated with a slightly greater interest in using the vaginal ring? If you said “tampon...
by Laura Wershler | Apr 20, 2010 | Birth Control, Newspapers, Pharmaceutical, Philosophy
I read The Birth-Control Riddle by Melinda Beck, published today in The Wall Street Journal with interest and frustration. As a veteran pro-choice sexual and reproductive health advocate, I’ve spent decades contemplating this “riddle”. I have two specific...
by Chris Hitchcock | Apr 20, 2010 | Birth Control, Health Care, Menstruation, Ovulation, Pharmaceutical, Reproduction, Sex
It’s starting. With the approaching 50th anniversary of the birth control pill, there will be a flood of anniversary celebrations and reviews of birth control methods. Which is good. We should have those discussions more often. Just say “no” (on the...
by Elizabeth Kissling | Apr 3, 2010 | Birth Control, Menstruation, New Research, Pharmaceutical
We’ve mentioned Yaz and its sister drug Yasmin before, and our friend Holly Grigg-Spall tracks the progress of complaints against them and other oral contraceptives. Yaz and Yasmin were Bayer’s top-selling drugs in 2008, bringing in about $1.8 billion, a 17...
by Chris Bobel | Mar 31, 2010 | Advertising, Menstruation, New Research, Pharmaceutical
Today, there’s a front page story in the New York Times about Astra-Zeneca’s move to market their cholesterol pills (known as statins, and as the NYT reports, already the most prescribed drugs in the US) at healthy people in spite of unresolved concerns...
